#disease
CNBC’s Becky Quick to Moderate High-Level CEO Dialogue on the Future of Rare Disease Innovation at NORD’s 2026 Breakthrough Summit
WASHINGTON, D.C. and NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has announced that prominent business...
NORD Applauds FDA Initiative to Develop New Regulatory Framework for Rare Disease Drug Development
NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has issued a strong statement of support for...
TSC and Me: Building a Connected Community and Amplifying Voices in Rare Disease Awareness
A new social media initiative has been launched to unite individuals, families, and caregivers affected by Tuberous Sclerosis...
TSC and Me: Building a Connected Community and Amplifying Voices in Rare Disease Awareness
A new nationwide initiative has been launched to foster deep connections and combat isolation among individuals and families affected by...
NORD Announces Funding Opportunity to Launch Two New Rare Disease Patient Registries on the IAMRARE Platform
NORWELL, Mass., Oct. 21, 2026 — The National Organization for Rare Disorders (NORD®) has officially announced a new request for...
NORD and Critical Path Institute Announce Funding Opportunity to Launch Two New Rare Disease Patient Registries on the IAMRARE Platform
NORWELL, Mass., Oct. 21, 2026 — The National Organization for Rare Disorders (NORD®) has officially announced a new request for...
NORD Applauds FDA Initiative to Establish New Regulatory Framework for Rare Disease Drug Development
NORWELL, Mass. — In what patient advocates are hailing as a monumental step forward for millions of families, the National...
NORD Applauds FDA’s Landmark Initiative to Establish Tailored Regulatory Framework for Rare Disease Drug Development
NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has issued a resounding endorsement of the U.S. Food and...
TSC and Me: Building a Connected Community and Amplifying Voices in Rare Disease Advocacy
The global community affected by Tuberous Sclerosis Complex (TSC) is stepping forward into the digital spotlight with the launch of...
NORD Applauds FDA’s Landmark Initiative to Establish a Tailored Regulatory Framework for Rare Disease Drug Development
NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has issued a strong statement of support for the U.S....
